B. Sherman

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

Joyce O’Shaughnessy, Cynthia R. Osborne, John Pippen et al. · Journal of Clinical Oncology · 2009 · 243 citations

Surgical Oncology, Breast Oncology, Tumoral Pathology +15

Echocardiographic evaluation of pericardial effusion in myxedema. Incidence and biochemical and clinical correlations.

R E Kerber, B. Sherman · Circulation · 1975 · 103 citations

Pericardial Effusion, Cardiovascular Disease, Low Voltage +15

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

Joyce O’Shaughnessy, C. Osborne, John Pippen et al. · Journal of Clinical Oncology · 2009 · 94 citations

Breast Oncology, Medicine, Pharmacology +11

Recombinant growth hormone treatment of amyotrophic lateral sclerosis

Richard Smith, B. Sherman, J. France et al. · Muscle & Nerve · 1993 · 70 citations

Muscle 75, Amyotrophic Lateral Sclerosis, Kinesiology +14

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

Joyce O’Shaughnessy, C. Osborne, John Pippen et al. · Journal of Clinical Oncology · 2009 · 44 citations

Tumor Biology, Breast Oncology, Oncology +11